Ticker Details
Pyxis Oncology, Inc.
IPO Date:	October 8, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$167.26M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 4.77%
Avg Daily Range (30 D):	$0.16 | 6.99%
Avg Daily Range (90 D):	$0.11 | 5.72%

Institutional Daily Volume
Avg Daily Volume:	.64M
Avg Daily Volume (30 D):	1.05M
Avg Daily Volume (90 D):	.65M

Trade Size
Avg Trade Size (Sh.):	180
Avg Trade Size (Sh.) (30 D):	142
Avg Trade Size (Sh.) (90 D):	142

Institutional Trades
Total Institutional Trades:	58
Avg Institutional Trade:	$1.94M
Avg Institutional Trade (30 D):	$.83M
Avg Institutional Trade (90 D):	$.83M
Avg Institutional Trade Volume:	.57M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.68M
Avg Closing Trade (30 D):	$4.38M
Avg Closing Trade (90 D):	$4.38M
Avg Closing Volume:	1.47M

News

Jun 28, 2024 @ 8:30 PM Pyxis Oncology Reports Inducement Grants Under Nas... Source: Pyxis Oncology

Jun 10, 2024 @ 11:30 AM Pyxis Oncology Expands Board of Directors with App... Source: Pyxis Oncology

May 30, 2024 @ 11:30 AM Pyxis Oncology to Participate in a Fireside Chat a... Source: Pyxis Oncology

May 14, 2024 @ 12:40 PM Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research

Apr 12, 2024 @ 1:55 PM Does Pyxis Oncology (PYXS) Have the Potential to R... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.31	$-.37	$-.29
Diluted EPS	$-1.31	$-.37	$-.29
Revenue	$13.86M	$M	$11.04M
Gross Profit
Net Income / Loss	$-81.74M	$-23.27M	$-18.11M
Operating Income / Loss	$-85.87M	$-24.36M	$-18.3M
Cost of Revenue
Net Cash Flow	$-13.71M	$-9.66M	$6.5M
PE Ratio